OXYGENTA PHARMACEUTICAL Announcements
Closure of Trading Window for the period ending on 31.03.2026.
25 Mar, 2026 | 04:47pm • Source: BSE
Disclosure under Regulation 30 of SEBI (Listing Obligations and Discloure Requirements) Regulations, 2015.
20 Feb, 2026 | 04:36pm • Source: BSE
Un-audited Results for the Quarter and nine months ended 31.12.2025.
04 Feb, 2026 | 06:09pm • Source: BSE
With reference to the subject cited, this is to inform the Exchange that the Board of Directors of Oxygenta Pharmaceutical Limited, at its Meeting held...
04 Feb, 2026 | 06:02pm • Source: BSE
Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended 31st December, 2025.
12 Jan, 2026 | 05:59pm • Source: BSE
Closure of Trading Window under SEBI (Prohibition of Insier Trading) Regulations, 2015 for the period ending on December 31, 2025.
29 Dec, 2025 | 03:02pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd
17 Dec, 2025 | 04:50pm • Source: BSE
Submission of Newspaper Publications
12 Nov, 2025 | 03:35pm • Source: BSE
Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclsoure Requirements), Regulations, 2015.
11 Nov, 2025 | 05:56pm • Source: BSE
Appointment of Mr. Prasad Reddy Battinapatla as Chief Financial Officer of the Company
07 Nov, 2025 | 06:17pm • Source: BSE
Un Audited financial results for the Quarter and Half year ended 30.09.2025
07 Nov, 2025 | 06:13pm • Source: BSE
Outcome of the Board meeting held on 07.11.2025
07 Nov, 2025 | 06:06pm • Source: BSE
Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and...
03 Nov, 2025 | 05:23pm • Source: BSE
Intimation of Issuance of Duplicate Share Certificate
18 Oct, 2025 | 10:08pm • Source: BSE
Compliance as per Regulation 74(5) of SEBI(Depositories and Participants), Regulations, 2018 for the Quarter ended 30th September, 2025.
18 Oct, 2025 | 08:33pm • Source: BSE
Intimation of Receipt of No-objection from BSE Limited (BSE) for reclassification from "Promoter/ Promoter Group" Category to "Public" Category shareholder of the Company pursuant to...
16 Oct, 2025 | 07:01pm • Source: BSE
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015.
26 Sep, 2025 | 07:06pm • Source: BSE
Secrutinzers Report and Voting Results for AGM held on 19.09.2025
19 Sep, 2025 | 08:52pm • Source: BSE
Outcome of the 32nd Annual General Meeting of the Company.
19 Sep, 2025 | 08:48pm • Source: BSE